• A 83-01: Selective ALK-5 Inhibitor Guide

  2026-10-01

  A 83-01 is a selective ALK-5 inhibitor that suppresses TGF-β/Smad signaling and supports epithelial-mesenchymal transition (EMT) research. Product-reported activity includes an approximately 12 nM IC50 and 68% inhibition of ALK-5-induced reporter activity at 1 μM in Mv1LuR4-2 cells.

• Imipramine: A Smarter Autophagy Assay Strategy

  2026-10-01

  Imipramine is a tricyclic antidepressant with applications spanning glioma cell autophagy research, apoptosis assays, and neurobiology. This article develops a decision framework that connects the compound’s research profile with ceramide-driven autophagy findings while clearly separating evidence from testable hypotheses.

• SB 431542 Workflow for ALK5 Inhibition

  2026-09-30

  SB 431542 provides a practical way to test ALK5-dependent TGF-β responses in cancer, immune, and stem/progenitor-cell assays. This workflow combines mechanism-based controls with the long-term myogenic engraftment framework reported in a 2025 human PSC study, while emphasizing dose selection, timing, and interpretation limits.

• N4-Acetylcytidine: RNA Modification Workflows

  2026-09-30

  N4-Acetylcytidine supports controlled studies of free ac4C metabolism, post-transcriptional RNA modification, and enzyme substrate specificity. This guide separates RNA-embedded biology from free acetylated cytidine assays, with practical preparation, controls, troubleshooting, and structure-guided applications.

• Human iPSC Sensory Neurons Model HSV-1 Latency

  2026-09-29

  Oh et al. developed a scalable human induced pluripotent stem cell system that rapidly produces functional sensory neurons and supports experimentally defined HSV-1 latency and reactivation. The model combines neuronal physiology with virological, transcriptional, and chromatin-based validation, offering a human-relevant platform for studying neuron-intrinsic mechanisms and testing latency-directed interventions.

• TBXA2R–ERM Signaling in TNBC Metastasis

  2026-09-29

  The reference study identifies TBXA2R as a GPCR that activates ezrin, radixin, and moesin through Gαq/11, Gα12/13, Rho GTPases, and the kinases SLK and LOK. This signaling axis links receptor activity to triple-negative breast cancer cell motility, invasion, and metastatic colonization, establishing ERM function as a mechanistic requirement rather than a passive correlate.

• Necrosulfonamide Workflows for MLKL Research

  2026-09-28

  Necrosulfonamide provides a selective way to test whether membrane-disruptive necroptosis, rather than apoptosis, drives a radiation response. This practical guide connects NSA handling and assay controls with carbon-ion cancer research, emphasizing interpretable workflows and troubleshooting.

• A 83-01 ALK-5 Inhibitor for Kidney Fibrosis

  2026-09-28

  Use A 83-01 to test whether ALK-5-dependent TGF-β signaling contributes to fibroblast activation—not as a stand-in for Spp1 perturbation. This kidney-fibrosis workflow pairs carefully controlled inhibitor dosing with early Smad readouts and later myofibroblast markers, while flagging selectivity and vehicle controls that matter for interpretation.

• AT-406 in TNBC: Reading Cell Death Beyond Apoptosis

  2026-09-27

  AT-406 (SM-406) can help researchers interrogate how IAP inhibition reshapes cell-death responses in cancer models. This article examines recent TNBC findings and translates them into a practical framework for distinguishing apoptosis from necroptosis-like and autophagy-associated signals.

• Risedronate Sodium: Practical Bone and Lung Workflows

  2026-09-26

  Turn Risedronate Sodium’s FPPS inhibition into practical workflows for osteoclast and pulmonary-delivery studies, with dose-screening, formulation, and troubleshooting guidance. A lung-targeted Risedronate/vitamin D₃ study offers a useful nanoparticle benchmark while also clarifying what remains preclinical.

• DEBIO 1143 in Murine TNBC: Cell-Death Mechanisms

  2026-09-25

  This study combines cell-based assays with molecular docking and 1-μs molecular-dynamics simulations to examine DEBIO 1143 in murine breast cancer models. Its findings link cIAP1 depletion with cytotoxicity and increased autophagy-associated and necroptosis-like responses, while cautioning that these changes do not establish direct drug binding to the measured downstream mediators.

• Angiotensin Peptides Enhance SARS-CoV-2 Spike Binding

  2026-09-25

  Oliveira and colleagues report that several naturally occurring angiotensin peptides enhance SARS-CoV-2 spike-protein binding to host-cell receptors, with effects that depend on peptide length and sequence. The findings identify a possible biochemical connection between renin–angiotensin system peptides and viral receptor binding, but do not establish that these interactions increase infection in cells or disease in vivo.

• FOXO3 Blocks Dual Metabolism in HCC

  2026-09-24

  The study identifies FOXO3 as a tumor suppressor that represses YAP and coordinately limits glycolysis and glutaminolysis in hepatocellular carcinoma. Its cell, in vivo, and patient-derived organoid findings support the FOXO3/YAP axis as a preclinical strategy for disrupting metabolic adaptation, while leaving important questions about clinical translation unresolved.

• SB525334 (TGF-beta1 receptor inhibitor): Lab Guide

  2026-09-24

  A practical guide to using SB525334 (TGF-beta1 receptor inhibitor), SKU A5602, to investigate ALK5-dependent signaling in cell-based and renal fibrosis research. Covers assay interpretation, compound handling, evidence from a diabetic wound-healing study, and grounded criteria for selecting a supplier.

• Machine Learning Reveals Three Senolytic Candidates

  2026-09-23

  The study used machine learning trained on published data to prioritize compounds for senolytic testing, then validated ginkgetin, periplocin, and oleandrin in human cell models of senescence. Its main contribution is a data-efficient route from scattered literature results to experimentally testable candidates, while highlighting the need to confirm selectivity across cell types and senescence models.

8596 records 1/574 page Next 12345 下5页 Last page